A pharmacodynamic study of quazepam and triazolam

G. Casucci, A. Di Costanzo, R. Riva, S. Allocca, G. Tedeschi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A double-blind single oral dose study in 10 healthy volunteers was performed during the day to compare the diurnal effects of quazepam (15 mg) and triazolam (0.25 mg) on psychomotor performance. The central effect of the two benzodiazepines was assessed by means of a computer analysis of visually guided saccadic eye movements (SEM), critical flicker fusion threshold (CFFT), and choice reaction time (CRT). The results obtained suggest that: computer analysis of SEM is more sensitive than CRT and CFFT to detect sedative drug effects at a subclinical level; the presumed equipotent doses of quazepam and triazolam tested do not show the same sedative activity; the minimal impairment produced by quazepam on CNS function does not seem to be related to the property to bind to BZ1 receptors; the pharmacodynamic profile of quazepam seems to be characteristic of a 'non-sedative' agent, while triazolam behaves as a 'sedative' benzodiazepine.

Original languageEnglish
Pages (from-to)293-299
Number of pages7
JournalHuman Psychopharmacology
Volume6
Issue number4
DOIs
Publication statusPublished - 1991

Fingerprint

Triazolam
Hypnotics and Sedatives
Flicker Fusion
Saccades
Benzodiazepines
Reaction Time
Psychomotor Performance
Healthy Volunteers
quazepam
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Psychology(all)
  • Neuroscience(all)
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Neurology
  • Clinical Neurology

Cite this

Casucci, G., Di Costanzo, A., Riva, R., Allocca, S., & Tedeschi, G. (1991). A pharmacodynamic study of quazepam and triazolam. Human Psychopharmacology, 6(4), 293-299. https://doi.org/10.1002/hup.470060405

A pharmacodynamic study of quazepam and triazolam. / Casucci, G.; Di Costanzo, A.; Riva, R.; Allocca, S.; Tedeschi, G.

In: Human Psychopharmacology, Vol. 6, No. 4, 1991, p. 293-299.

Research output: Contribution to journalArticle

Casucci, G, Di Costanzo, A, Riva, R, Allocca, S & Tedeschi, G 1991, 'A pharmacodynamic study of quazepam and triazolam', Human Psychopharmacology, vol. 6, no. 4, pp. 293-299. https://doi.org/10.1002/hup.470060405
Casucci, G. ; Di Costanzo, A. ; Riva, R. ; Allocca, S. ; Tedeschi, G. / A pharmacodynamic study of quazepam and triazolam. In: Human Psychopharmacology. 1991 ; Vol. 6, No. 4. pp. 293-299.
@article{3434afea6a03433ab015b6bb6ff46e38,
title = "A pharmacodynamic study of quazepam and triazolam",
abstract = "A double-blind single oral dose study in 10 healthy volunteers was performed during the day to compare the diurnal effects of quazepam (15 mg) and triazolam (0.25 mg) on psychomotor performance. The central effect of the two benzodiazepines was assessed by means of a computer analysis of visually guided saccadic eye movements (SEM), critical flicker fusion threshold (CFFT), and choice reaction time (CRT). The results obtained suggest that: computer analysis of SEM is more sensitive than CRT and CFFT to detect sedative drug effects at a subclinical level; the presumed equipotent doses of quazepam and triazolam tested do not show the same sedative activity; the minimal impairment produced by quazepam on CNS function does not seem to be related to the property to bind to BZ1 receptors; the pharmacodynamic profile of quazepam seems to be characteristic of a 'non-sedative' agent, while triazolam behaves as a 'sedative' benzodiazepine.",
author = "G. Casucci and {Di Costanzo}, A. and R. Riva and S. Allocca and G. Tedeschi",
year = "1991",
doi = "10.1002/hup.470060405",
language = "English",
volume = "6",
pages = "293--299",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - A pharmacodynamic study of quazepam and triazolam

AU - Casucci, G.

AU - Di Costanzo, A.

AU - Riva, R.

AU - Allocca, S.

AU - Tedeschi, G.

PY - 1991

Y1 - 1991

N2 - A double-blind single oral dose study in 10 healthy volunteers was performed during the day to compare the diurnal effects of quazepam (15 mg) and triazolam (0.25 mg) on psychomotor performance. The central effect of the two benzodiazepines was assessed by means of a computer analysis of visually guided saccadic eye movements (SEM), critical flicker fusion threshold (CFFT), and choice reaction time (CRT). The results obtained suggest that: computer analysis of SEM is more sensitive than CRT and CFFT to detect sedative drug effects at a subclinical level; the presumed equipotent doses of quazepam and triazolam tested do not show the same sedative activity; the minimal impairment produced by quazepam on CNS function does not seem to be related to the property to bind to BZ1 receptors; the pharmacodynamic profile of quazepam seems to be characteristic of a 'non-sedative' agent, while triazolam behaves as a 'sedative' benzodiazepine.

AB - A double-blind single oral dose study in 10 healthy volunteers was performed during the day to compare the diurnal effects of quazepam (15 mg) and triazolam (0.25 mg) on psychomotor performance. The central effect of the two benzodiazepines was assessed by means of a computer analysis of visually guided saccadic eye movements (SEM), critical flicker fusion threshold (CFFT), and choice reaction time (CRT). The results obtained suggest that: computer analysis of SEM is more sensitive than CRT and CFFT to detect sedative drug effects at a subclinical level; the presumed equipotent doses of quazepam and triazolam tested do not show the same sedative activity; the minimal impairment produced by quazepam on CNS function does not seem to be related to the property to bind to BZ1 receptors; the pharmacodynamic profile of quazepam seems to be characteristic of a 'non-sedative' agent, while triazolam behaves as a 'sedative' benzodiazepine.

UR - http://www.scopus.com/inward/record.url?scp=0025880962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025880962&partnerID=8YFLogxK

U2 - 10.1002/hup.470060405

DO - 10.1002/hup.470060405

M3 - Article

AN - SCOPUS:0025880962

VL - 6

SP - 293

EP - 299

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 4

ER -